IMNM
Price
$9.99
Change
+$0.13 (+1.32%)
Updated
Jan 17 closing price
Capitalization
623.54M
67 days until earnings call
SLDB
Price
$3.27
Change
+$0.02 (+0.62%)
Updated
Jan 17 closing price
Capitalization
130.65M
Ad is loading...

IMNM vs SLDB

Header iconIMNM vs SLDB Comparison
Open Charts IMNM vs SLDBBanner chart's image
Immunome
Price$9.99
Change+$0.13 (+1.32%)
Volume$900.33K
Capitalization623.54M
Solid Biosciences
Price$3.27
Change+$0.02 (+0.62%)
Volume$495.11K
Capitalization130.65M
IMNM vs SLDB Comparison Chart
Loading...
IMNM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SLDB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IMNM vs. SLDB commentary
Jan 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IMNM is a Hold and SLDB is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 19, 2025
Stock price -- (IMNM: $9.99 vs. SLDB: $3.27)
Brand notoriety: IMNM and SLDB are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IMNM: 96% vs. SLDB: 114%
Market capitalization -- IMNM: $623.54M vs. SLDB: $130.65M
IMNM [@Biotechnology] is valued at $623.54M. SLDB’s [@Biotechnology] market capitalization is $130.65M. The market cap for tickers in the [@Biotechnology] industry ranges from $368.92B to $0. The average market capitalization across the [@Biotechnology] industry is $2.37B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IMNM’s FA Score shows that 0 FA rating(s) are green whileSLDB’s FA Score has 2 green FA rating(s).

  • IMNM’s FA Score: 0 green, 5 red.
  • SLDB’s FA Score: 2 green, 3 red.
According to our system of comparison, SLDB is a better buy in the long-term than IMNM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IMNM’s TA Score shows that 3 TA indicator(s) are bullish while SLDB’s TA Score has 4 bullish TA indicator(s).

  • IMNM’s TA Score: 3 bullish, 4 bearish.
  • SLDB’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, SLDB is a better buy in the short-term than IMNM.

Price Growth

IMNM (@Biotechnology) experienced а -5.75% price change this week, while SLDB (@Biotechnology) price change was -11.14% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.44%. For the same industry, the average monthly price growth was +2.66%, and the average quarterly price growth was -1.92%.

Reported Earning Dates

IMNM is expected to report earnings on May 08, 2025.

SLDB is expected to report earnings on May 11, 2023.

Industries' Descriptions

@Biotechnology (-1.44% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IMNM($624M) has a higher market cap than SLDB($131M). IMNM YTD gains are higher at: -5.932 vs. SLDB (-18.250). SLDB (-108.63M) and IMNM (-109.95M) have comparable annual earnings (EBITDA) . IMNM has more cash in the bank: 240M vs. SLDB (171M). IMNM has less debt than SLDB: IMNM (2.72M) vs SLDB (24.7M). IMNM has higher revenues than SLDB: IMNM (10.1M) vs SLDB (0).
IMNMSLDBIMNM / SLDB
Capitalization624M131M476%
EBITDA-109.95M-108.63M101%
Gain YTD-5.932-18.25033%
P/E RatioN/AN/A-
Revenue10.1M0-
Total Cash240M171M140%
Total Debt2.72M24.7M11%
FUNDAMENTALS RATINGS
SLDB: Fundamental Ratings
SLDB
OUTLOOK RATING
1..100
67
VALUATION
overvalued / fair valued / undervalued
1..100
19
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
96
P/E GROWTH RATING
1..100
3
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
IMNMSLDB
RSI
ODDS (%)
Bullish Trend 11 days ago
90%
Bullish Trend 11 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 11 days ago
88%
Bullish Trend 11 days ago
77%
Momentum
ODDS (%)
Bearish Trend 11 days ago
90%
Bearish Trend 11 days ago
87%
MACD
ODDS (%)
N/A
Bullish Trend 11 days ago
76%
TrendWeek
ODDS (%)
Bullish Trend 11 days ago
84%
Bullish Trend 11 days ago
81%
TrendMonth
ODDS (%)
Bearish Trend 11 days ago
86%
Bearish Trend 11 days ago
90%
Advances
ODDS (%)
Bullish Trend 24 days ago
81%
Bullish Trend 24 days ago
80%
Declines
ODDS (%)
Bearish Trend 11 days ago
86%
Bearish Trend 12 days ago
90%
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
Bearish Trend 11 days ago
82%
Bearish Trend 11 days ago
90%
View a ticker or compare two or three
Ad is loading...
IMNM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SLDB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
NWJFX106.870.93
+0.88%
Nationwide NYSE Arca Tech 100 Idx InsSvc
TRVPX18.390.10
+0.55%
Nuveen Mid Cap Value Premier
FCPAX30.190.16
+0.53%
Fidelity Advisor Intl Capl App A
PINIX12.69N/A
N/A
Principal International Equity Inst
RRSVX16.10N/A
N/A
RBC Small Cap Value R6

IMNM and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMNM has been loosely correlated with BEAM. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if IMNM jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMNM
1D Price
Change %
IMNM100%
+1.32%
BEAM - IMNM
47%
Loosely correlated
+0.17%
ATXS - IMNM
46%
Loosely correlated
-3.23%
RXRX - IMNM
45%
Loosely correlated
+2.03%
ABSI - IMNM
44%
Loosely correlated
+3.57%
KYMR - IMNM
44%
Loosely correlated
+0.79%
More

SLDB and

Correlation & Price change

A.I.dvisor indicates that over the last year, SLDB has been loosely correlated with TRDA. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if SLDB jumps, then TRDA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SLDB
1D Price
Change %
SLDB100%
+0.62%
TRDA - SLDB
42%
Loosely correlated
+1.20%
MGTX - SLDB
41%
Loosely correlated
+5.56%
ACLX - SLDB
41%
Loosely correlated
-0.79%
IMNM - SLDB
39%
Loosely correlated
+1.32%
PRME - SLDB
39%
Loosely correlated
+0.70%
More